Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants.

Kamili S.

Antivir Ther. 2010;15(3 Pt B):477-85. doi: 10.3851/IMP1520. Review.

PMID:
20516568
2.

Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants.

Chang MH.

Antivir Ther. 2010;15(3 Pt B):463-9. doi: 10.3851/IMP1555. Review.

PMID:
20516566
3.

Drug-resistant and immune-escape HBV mutants in HIV-infected hosts.

Lacombe K, Boyd A, Gozlan J, Lavocat F, Girard PM, Zoulim F.

Antivir Ther. 2010;15(3 Pt B):493-7. doi: 10.3851/IMP1495. Review.

5.

Hepatitis B vaccination.

Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR.

Hum Vaccin Immunother. 2015;11(1):53-7. doi: 10.4161/hv.34306. Epub 2014 Nov 1. Review.

6.

Mutations of the surface protein of hepatitis B virus.

Zuckerman JN, Zuckerman AJ.

Antiviral Res. 2003 Oct;60(2):75-8. Review.

PMID:
14638401
7.
8.

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

Cassidy A, Mossman S, Olivieri A, De Ridder M, Leroux-Roels G.

Expert Rev Vaccines. 2011 Dec;10(12):1709-15. doi: 10.1586/erv.11.151. Review. Erratum in: Expert Rev Vaccines. 2012 Jan;11(1):120.

PMID:
22085174
9.

Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy.

Luongo M, Critelli R, Grottola A, Gitto S, Bernabucci V, Bevini M, Vecchi C, Montagnani G, Villa E.

J Clin Virol. 2015 Jan;62:89-91. doi: 10.1016/j.jcv.2014.11.029. Epub 2014 Nov 29. Review.

PMID:
25542480
10.

[Hepatitis B virus mutants--clinical significance].

Blum HE, Moradpour D, vøn Weizsäcker F, Wieland S, Peters T, Rasenack JW.

Z Gastroenterol. 1997 May;35(5):347-55. Review. German.

PMID:
9265394
11.

Effect of hepatitis B virus mutants on efficacy of vaccination.

Zuckerman AJ.

Lancet. 2000 Apr 22;355(9213):1382-4. Review. No abstract available.

PMID:
10791517
12.

Unsolved problems and future perspectives of hepatitis B virus vaccination.

Tajiri K, Shimizu Y.

World J Gastroenterol. 2015 Jun 21;21(23):7074-83. doi: 10.3748/wjg.v21.i23.7074. Review.

13.

[Hepatitis B vaccine].

Kurokohchi K, Kuriyama S.

Nihon Rinsho. 2005 May;63 Suppl 5:638-42. Review. Japanese. No abstract available.

PMID:
15954422
14.

The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.

Joung YH, Park SH, Moon KB, Jeon JH, Cho HS, Kim HS.

Int J Mol Sci. 2016 Oct 13;17(10). pii: E1715. Review.

15.

[HB vaccine escape mutant].

Homma S.

Nihon Rinsho. 2004 Aug;62 Suppl 8:51-3. Review. Japanese. No abstract available.

PMID:
15453284
16.
17.

Perspectives on hepatitis B studies with chimpanzees.

Prince AM, Brotman B.

ILAR J. 2001;42(2):85-8. Review.

PMID:
11406710
18.

[Establishment of in vitro model for HBV infection via asialoglycoprotein receptor].

Neda H, Niitsu Y.

Nihon Rinsho. 1995 Oct;53 Suppl(Pt 2):121-4. Review. Japanese. No abstract available.

PMID:
12442372
19.

Do single nucleotide mutations result in clinically significant changes in hepatitis B virus pathogenicity?

Alberti A.

J Hepatol. 1990 May;10(3):268-70. Review. No abstract available.

PMID:
2195105

Supplemental Content

Support Center